1-20 of 51
Section: Review Article
Journal Article
ACCEPTED MANUSCRIPT
A Review of Conjugation Technologies for Antibody Drug Conjugates
Antibody Therapeutics, tbaf010, https://doi.org/10.1093/abt/tbaf010
Published: 17 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors
Antibody Therapeutics, tbaf004, https://doi.org/10.1093/abt/tbaf004
Published: 18 March 2025
Journal Article
A systematic review of the avian antibody (IgY) therapeutic effects on human bacterial infections over the decade
Antibody Therapeutics, Volume 8, Issue 2, April 2025, Pages 111–123, https://doi.org/10.1093/abt/tbaf007
Published: 09 March 2025
Journal Article
Fc gamma receptor polymorphisms in antibody therapy: implications for bioassay development to enhance product quality
Antibody Therapeutics, Volume 8, Issue 2, April 2025, Pages 87–98, https://doi.org/10.1093/abt/tbaf003
Published: 21 January 2025
Journal Article
Current use and development of monoclonal antibodies for the treatment of systemic lupus erythematosus: a review
Antibody Therapeutics, Volume 8, Issue 1, January 2025, Pages 47–55, https://doi.org/10.1093/abt/tbae033
Published: 26 December 2024
Journal Article
Connexin 43 hemichannels and related diseases
Antibody Therapeutics, Volume 7, Issue 4, October 2024, Pages 361–369, https://doi.org/10.1093/abt/tbae024
Published: 11 November 2024
Journal Article
Structure and function of therapeutic antibodies approved by the US FDA in 2023
Antibody Therapeutics, Volume 7, Issue 2, April 2024, Pages 132–156, https://doi.org/10.1093/abt/tbae007
Published: 19 March 2024
Journal Article
Next generation of multispecific antibody engineering
Antibody Therapeutics, Volume 7, Issue 1, January 2024, Pages 37–52, https://doi.org/10.1093/abt/tbad027
Published: 08 December 2023
Journal Article
CD80-Fc fusion protein as a potential cancer immunotherapy strategy
Antibody Therapeutics, Volume 7, Issue 1, January 2024, Pages 28–36, https://doi.org/10.1093/abt/tbad029
Published: 30 November 2023
Journal Article
Challenges and solutions for the downstream purification of therapeutic proteins
Antibody Therapeutics, Volume 7, Issue 1, January 2024, Pages 1–12, https://doi.org/10.1093/abt/tbad028
Published: 19 November 2023
Journal Article
Mapping the protein–protein interactome in the tumor immune microenvironment
Antibody Therapeutics, Volume 6, Issue 4, October 2023, Pages 311–321, https://doi.org/10.1093/abt/tbad026
Published: 14 November 2023
Journal Article
Effects of arginine in therapeutic protein formulations: a decade review and perspectives
Antibody Therapeutics, Volume 6, Issue 4, October 2023, Pages 265–276, https://doi.org/10.1093/abt/tbad022
Published: 12 October 2023
Journal Article
Bringing cell therapy to tumors: considerations for optimal CAR binder design
Antibody Therapeutics, Volume 6, Issue 4, October 2023, Pages 225–239, https://doi.org/10.1093/abt/tbad019
Published: 12 September 2023
Journal Article
Current status of drug development for patients with multiple myeloma: a review of comparison in China and the rest of world
Antibody Therapeutics, Volume 6, Issue 2, April 2023, Pages 127–136, https://doi.org/10.1093/abt/tbad010
Published: 11 May 2023
Journal Article
Beyond antibody fucosylation: α-(1,6)-fucosyltransferase (Fut8) as a potential new therapeutic target for cancer immunotherapy
Antibody Therapeutics, Volume 6, Issue 2, April 2023, Pages 87–96, https://doi.org/10.1093/abt/tbad004
Published: 02 March 2023
Journal Article
Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics
Antibody Therapeutics, Volume 6, Issue 1, January 2023, Pages 13–29, https://doi.org/10.1093/abt/tbac029
Published: 11 November 2022
Journal Article
Engineering antibody and protein therapeutics to cross the blood–brain barrier
Antibody Therapeutics, Volume 5, Issue 4, October 2022, Pages 311–331, https://doi.org/10.1093/abt/tbac028
Published: 09 November 2022
Journal Article
The global landscape of approved antibody therapies
Antibody Therapeutics, Volume 5, Issue 4, October 2022, Pages 233–257, https://doi.org/10.1093/abt/tbac021
Published: 06 September 2022
Journal Article
Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective
Antibody Therapeutics, Volume 5, Issue 3, July 2022, Pages 164–176, https://doi.org/10.1093/abt/tbac014
Published: 16 June 2022
Journal Article
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
Antibody Therapeutics, Volume 5, Issue 1, January 2022, Pages 73–83, https://doi.org/10.1093/abt/tbac006
Published: 23 February 2022
